Through the NA-ATTC, a collaboration between Dr Matthew Lakelin, (VP Business Development and Scientific Affairs, TrakCel), and Professor John Campbell (Director Tissues, Cells and Advanced Therapeutics, Scottish National Blood Transfusion Service) enabled TrakCel to produce an Exemplar process for managing an autologous therapy; specifically where the therapy’s starting material and drug product is not cryopreserved, adding to the complexities of managing the supply chain.
